A plasmid stabilization system, active in high copy-number plasmids, was cloned from the large resident plasmid, pSLT, of Salmonella typhimurium, The ytl2 gene, together with a 249-bp region (termed incR) downstream of the gene, imparted > 10(4)-fold stability to a pBR322-based plasmid, The ytl2-incR region was then used to stabilize a recombinant plasmid carrying the human epidermal growth factor gene (with the Escherichia coli K-12 ompA signal sequence), behind the lacUV5 promoter, In shake flask tests to optimize expression of human epidermal growth factor, loss of recombinant plasmid was <1\% when growth (both before and after induction with isopropyl-beta-D-galactopyranoside) took place even in the absence of antibiotic selection, and ...
We studied the transforming ability of the extracellular plasmid DNA released from a genetically eng...
We studied the transforming ability of the extracellular plasmid DNA released from a genetically eng...
Lee, KelvinThe annual global market for biopharmaceuticals is estimated at about $99 billion. Approx...
A plasmid stabilization system, active in high copy-number plasmids, was cloned from the large resid...
Recombinant Escherichia coli JM101 strains harbouring plasmids pWKW2 or lacUV5par8EGF, both encoding...
Several attempts have been made to produce the biologically active recombinant hEGF in enhanced quan...
The high stability and productivity of recently developed Escherichia coli JM101 strains expressing ...
Human epidermal growth factor (hEGF) was expressed and excreted into culture medium in an excretory ...
Fusion expression is a promising strategy for the production of bioactive peptides in Escherichia co...
Expression of eukaryotic proteins in E. coli often results in their aggregation. Proper folding and ...
Abstract. Expression of recombinant eukaryotic proteins in Escherichia coli often results in the for...
Different approaches are used to express recombinant proteins without the requirement of post-transl...
The expression of recombinant hEGF (human epidermal growth factor) in Escherichia coli was conducted...
Our success in producing an active epidermal growth factor receptor (EGFR) tyrosine kinase in Escher...
Our success in producing an active epidermal growth factor receptor (EGFR) tyrosine kinase in Escher...
We studied the transforming ability of the extracellular plasmid DNA released from a genetically eng...
We studied the transforming ability of the extracellular plasmid DNA released from a genetically eng...
Lee, KelvinThe annual global market for biopharmaceuticals is estimated at about $99 billion. Approx...
A plasmid stabilization system, active in high copy-number plasmids, was cloned from the large resid...
Recombinant Escherichia coli JM101 strains harbouring plasmids pWKW2 or lacUV5par8EGF, both encoding...
Several attempts have been made to produce the biologically active recombinant hEGF in enhanced quan...
The high stability and productivity of recently developed Escherichia coli JM101 strains expressing ...
Human epidermal growth factor (hEGF) was expressed and excreted into culture medium in an excretory ...
Fusion expression is a promising strategy for the production of bioactive peptides in Escherichia co...
Expression of eukaryotic proteins in E. coli often results in their aggregation. Proper folding and ...
Abstract. Expression of recombinant eukaryotic proteins in Escherichia coli often results in the for...
Different approaches are used to express recombinant proteins without the requirement of post-transl...
The expression of recombinant hEGF (human epidermal growth factor) in Escherichia coli was conducted...
Our success in producing an active epidermal growth factor receptor (EGFR) tyrosine kinase in Escher...
Our success in producing an active epidermal growth factor receptor (EGFR) tyrosine kinase in Escher...
We studied the transforming ability of the extracellular plasmid DNA released from a genetically eng...
We studied the transforming ability of the extracellular plasmid DNA released from a genetically eng...
Lee, KelvinThe annual global market for biopharmaceuticals is estimated at about $99 billion. Approx...